![]() ![]() ![]() They’ve even been able to install and run either Android Auto and/or Apple CarPlay, something ACO Tech is unlikely to support officially given their reluctance to include it so far. Recently, Proton X50 owners have figured out a way (a rather easy one) that allows them to ‘sideload’ apps into Atlas OS, which itself is built on the Android Open Source Project (AOSP). Rather than duplicating their music library to Joox, users would be more likely to listen to audio via Bluetooth to the head unit while using their mobile device to stream from other services such as Apple Music and, yes, Spotify.ĪCO Tech’s newest app addition does bring up the question of what others could be added to the roster. Previously, Proton had included the decent but far from outstanding Joox music as their audio streaming service of choice. Spotify is widely regarded as the most popular music streaming service in the world with over 80 million songs and millions of podcasts, some of which are exclusive to the platform. However, users can also install it via ACO Tech’s app marketplace, the A store. This comes after a newly inked partnership with Spotify, which also means that the Spotify app will come pre-installed in new Proton vehicles equipped with an infotainment system running Atlas OS. įor further information please contact: Oxurion NV Tom Graney Chief Executive Officer Tel: +32 16 75 13 10 Michael Dillen Chief Business Officer Tel: +32 16 75 13 10 S Conway Communications Mary T.ACO Tech, the software development firm behind the Atlas OS that powers the infotainment suite in the Iriz Persona, and soon-to-be X50, have announced the addition of Spotify music streaming.Īfter the functionality comes along via an over-the-air (OTA) software update, users will be able to stream music from the popular audio subscription service via a native app accessed via the head unit, regardless of whether the associated account uses the Free or Premium tier, as was rumoured previously.Īltas OS got Spotify for X50, Iriz, Persona ![]() Securities Act of 1933, as amended, or in compliance with an exemption therefrom, and in accordance with any applicable U.S. No securities of Oxurion may be offered or sold within the United States without registration under the U.S. This press release does not constitute an offer or invitation for the sale or purchase of securities or assets of Oxurion in any jurisdiction. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company’s Annual Report. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or any other reason. Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. Important information about forward-looking statementsĬertain statements in this press release may be considered "forward-looking”. The trial is evaluating THR-149 versus aflibercept, the market leader, in treating the up to 50% of patients with diabetic macular edema (DME) for whom the current standard of care is suboptimal. We look forward to sharing the top-line results from this trial next quarter, in which we hope to demonstrate the superior efficacy of THR-149 in addressing this large unmet need since DME remains the leading cause of blindness for working aged people.” Tom Graney, CEO of Oxurion, said: "We appreciate Atlas’s continued financial commitment to Oxurion and their confidence in THR-149 as we enter the final stretch of the KALAHARI trial. ![]() The conversion price is set at an eight percent discount to the average VWAP over the three lowest days in the ten consecutive trading days prior to the conversion notice. Under the terms of the Subscription Agreement, Atlas has committed to subscribe to up to EUR 20.8 million in mandatorily convertible bonds over a 24-month period, of which it has now subscribed to EUR 8.8 million. On August 10, 2023, the Company issued 40 convertible bonds with a value of EUR one million to Atlas. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |